Avantax Advisory Services’s Zosano Pharma Corporation ZSAN Stock Holding History

Avantax Advisory Services’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-286	Closed	-$2K	–	1407
2022 Q1	$2K	Hold	286	–	–	﹤0.01%	1277
2021 Q4	$5K	Hold	286	–	–	﹤0.01%	1242
2021 Q3	$7K	Hold	286	–	–	﹤0.01%	1175
2021 Q2	$10K	Hold	286	–	–	﹤0.01%	1136
2021 Q1	$12K	Buy	+286	New	+$12K	﹤0.01%	1028
2020 Q4	–	Sell	-286	Closed	-$16K	–	1396
2020 Q3	$16K	Buy	+286	New	+$13.3K	﹤0.01%	1360

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Avantax Advisory Services's ZSAN Position: Q2 2022 in Review

Avantax Advisory Services sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 286 shares — an estimated $2K sold.

Avantax Advisory Services first reported a position in ZSAN in Q3 2020 and held it in 6 quarters. The position peaked at $16K in Q3 2020. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Avantax Advisory Services reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Avantax Advisory Services sold 286 Zosano Pharma Corporation shares in Q2 2022, an estimated $2K.
Avantax Advisory Services first reported a position in Zosano Pharma Corporation in Q3 2020 and held it in 6 quarters.
Avantax Advisory Services's Zosano Pharma Corporation position peaked at $16K in Q3 2020.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Avantax Advisory Services's 13F filing for Q2 2022, filed 2 Aug 2022.